Vaccination helps reduce complications for pregnant women suffering from COVID-19 Omicron variant.

KARACHI -- In its latest '2022 INTERCOVID Study' conducted in 41 hospitals across 18 countries, including the Aga Khan University Hospital in Pakistan, the global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has cited that pregnant women who were vaccinated, were well protected against severe COVID-19 symptoms and complications and had a very low risk of admission to an intensive care unit. The study evaluated the impact of the COVID-19 Omicron variant on maternal and neonatal outcomes and the efficacy of vaccination to reduce the associated risks.

The researchers studied 1,545 pregnant women diagnosed with the variant and 3,073 non-diagnosed, concomitant pregnant women as controls. The in-depth research found out that although Omicron variant is associated with several severe risks for pregnant women, adequate vaccination dosage can limit its risks. In the study, the MRNA vaccines were most effective in preventing severe COVID-19 symptoms and complications, although viral vector vaccines with a booster also provided adequate protection.

The Aga Khan University's faculty Dr...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT